Guangzhou Medical University
Clinical trials sponsored by Guangzhou Medical University, explained in plain language.
-
New hope for deadly breast cancer spread: drug duo targets brain lining
Disease control Recruiting nowThis study tests a combination of two drugs—sacituzumab govitecan (given through a vein) and pemetrexed (given into the spinal fluid)—for people with HER2-negative breast cancer that has spread to the lining of the brain and spinal cord (leptomeningeal metastases). The goal is to…
Phase: PHASE1, PHASE2 • Sponsor: Guangzhou Medical University • Aim: Disease control
Last updated May 17, 2026 07:04 UTC
-
Double attack on brain metastases: new combo therapy shows promise for lung cancer patients
Disease control Recruiting nowThis study tests whether adding a chemotherapy drug (pemetrexed) directly into the spinal fluid to a standard targeted therapy pill (like osimertinib) works better than the pill alone for people with a specific type of lung cancer that has spread to the lining of the brain or spi…
Phase: NA • Sponsor: Guangzhou Medical University • Aim: Disease control
Last updated May 17, 2026 07:03 UTC
-
New hope for brain lining cancer: spinal chemotherapy after targeted drug failure
Disease control Recruiting nowThis study tests a chemotherapy drug called pemetrexed, given directly into the spinal fluid, for people with a specific type of lung cancer that has spread to the lining of the brain and spinal cord. The cancer has stopped responding to a higher dose of a targeted therapy. The g…
Phase: PHASE2 • Sponsor: Guangzhou Medical University • Aim: Disease control
Last updated May 15, 2026 11:56 UTC